GLP-1 also slows down how fast our stomach empties, which helps control how quickly food gets into our bloodstream
Los resultados se publicaron en Nature el 8 de abril de 2026
Plaintiffs in Ozempic litigation report injuries that have substantially impacted their health and quality of life: Gastroparesis (stomach paralysis) causing severe vomiting, inability to digest food properly, and malnutrition requiring feeding tubes Non-arteritic anterior ischemic optic neuropathy (NAION) resulting in sudden, permanent vision loss affecting one or both eyes Ileus and intestinal obstruction requiring emergency hospitalization and surgical procedures Severe gastrointestinal complications including bowel perforation and chronic digestive dysfunction Gallbladder disease necessitating surgical removal Aspiration pneumonia from persistent vomiting and impaired gastric emptying Gastroparesis affects approximately 4% of the population, but studies show that patients with definite gastroparesis have a 5-year survival rate of only 67% considerably lower than the 81% expected survival rate in the general population

Over time, insulin sensitivity improves, inflammation decreases, and appetite regulation becomes more stable
Ethics declarations Conflict of Interest Andreea Ciudin: Honoraria from AstraZeneca, Boehringer Ingelheim, Lilly, Novo Nordisk